Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Galimberti

Showing results (401-410 of 526) with videos related to

Pageof 53
Sort By:
Molecular Neurodegeneration|November 16, 2023
Altered plasma protein profiles in genetic FTD - a GENFI studyAbbe Ullgren, Linn Öijerstedt, Jennie Olofsson, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid BiomarkersLinda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Neurology|September 4, 2025
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal DementiaIvana Kirilova Kancheva, Arabella Bouzigues, Lucy Louise Russell, et al.
Neurobiology of Aging|December 8, 2019
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's diseaseIrene Rosas, Carmen Martínez, Jordi Clarimón, et al.
Journal of Alzheimer'S Disease : JAD|January 24, 2022
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation CarriersEnrico Premi, Tommaso Costa, Stefano Gazzina, et al.
Brain : a Journal of Neurology|March 9, 2019
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI studyHenri J M M Mutsaerts, Saira S Mirza, Jan Petr, et al.
Neurobiology of Aging|January 12, 2011
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationsJean-Charles Lambert, Diana Zelenika, Mikko Hiltunen, et al.
Alzheimer'S Research & Therapy|July 13, 2021
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohortHannah D Franklin, Lucy L Russell, Georgia Peakman, et al.
Journal of Neurology|March 29, 2022
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutationsArabella Bouzigues, Lucy L Russell, Georgia Peakman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2023
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating ScalesKiran Samra, Amy Macdougall, Georgia Peakman, et al.
Pageof 53

Showing results (401-410 of 526) with videos related to

Sort By:
Pageof 53
Molecular Neurodegeneration|November 16, 2023
Altered plasma protein profiles in genetic FTD - a GENFI studyAbbe Ullgren, Linn Öijerstedt, Jennie Olofsson, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid BiomarkersLinda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Neurology|September 4, 2025
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal DementiaIvana Kirilova Kancheva, Arabella Bouzigues, Lucy Louise Russell, et al.
Neurobiology of Aging|December 8, 2019
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's diseaseIrene Rosas, Carmen Martínez, Jordi Clarimón, et al.
Journal of Alzheimer'S Disease : JAD|January 24, 2022
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation CarriersEnrico Premi, Tommaso Costa, Stefano Gazzina, et al.
Brain : a Journal of Neurology|March 9, 2019
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI studyHenri J M M Mutsaerts, Saira S Mirza, Jan Petr, et al.
Neurobiology of Aging|January 12, 2011
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationsJean-Charles Lambert, Diana Zelenika, Mikko Hiltunen, et al.
Alzheimer'S Research & Therapy|July 13, 2021
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohortHannah D Franklin, Lucy L Russell, Georgia Peakman, et al.
Journal of Neurology|March 29, 2022
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutationsArabella Bouzigues, Lucy L Russell, Georgia Peakman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2023
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating ScalesKiran Samra, Amy Macdougall, Georgia Peakman, et al.
Pageof 53